baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Cytokinetics Inc/ US23282W6057 /

2024-05-16 7:31:01 PM	Chg. -0.6300	Volume	Bid7:31:01 PM	Ask7:31:01 PM	High	Low
59.8700USD	-1.04%	231,577 Turnover: 9.24 mill.	59.8100Bid Size: 200	59.9100Ask Size: 100	61.0400	59.5000

GlobeNewswire 05-15 Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology...

GlobeNewswire 05-13 Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Se...

GlobeNewswire 05-13 Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...

GlobeNewswire 05-08 Cytokinetics Reports First Quarter 2024 Financial Results

GlobeNewswire 05-08 Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586

GlobeNewswire 05-08 Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population ...

GlobeNewswire 05-07 Cytokinetics to Hold Annual Meeting of Stockholders

GlobeNewswire 05-02 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 04-29 Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-...

GlobeNewswire 04-24 Cytokinetics to Announce First Quarter Results on May 8, 2024

GlobeNewswire 04-10 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at t...

GlobeNewswire 04-05 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...

GlobeNewswire 04-02 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 04-01 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire 03-25 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual...

GlobeNewswire 03-04 Cytokinetics to Participate in March Investor Conferences

GlobeNewswire 03-01 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 02-29 Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

GlobeNewswire 02-28 Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase E...

GlobeNewswire 02-27 Cytokinetics Reports Fourth Quarter 2023 Financial Results

GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results

GlobeNewswire 02-13 Cytokinetics to Announce Fourth Quarter Results on February 27, 2024

GlobeNewswire 02-06 Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire 01-29 Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program

Cytokinetics Inc/ US23282W6057 /

If you wish to receive reply to your feedback, please provide your email address.